Balyasny Asset Management
DCPH

Balyasny Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Balyasny Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
2024
Q1 		$185K Buy
2023
Q1 		– Sell
2022
Q4 		$22.8K Sell
2022
Q3 		$1.08M Buy
2018
Q2 		– Sell
2018
Q1 		$200K Buy